Dr. Brian M. Brady, M.D.
Nephrology (Kidney) (Nephrology Physician)
300 Pasteur Dr
Stanford, CA 94305
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Jefferson Medical College of Thomas Jefferson University (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 421
Licensed in California since 2015, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: Jefferson Medical College of Thomas Jefferson University
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
CA license A136657 (first issued 2015; current) -
Internal Medicine Physician
CA license A136657 (first issued 2015; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Stanford Health Care Stanford, CA
- Stanford Health Care Tri-Valley Pleasanton, CA
Medical groups
- Stanford Health Care (3,122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 421
- Services billed
- 838
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 277 | 218 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 138 | 65 |
| Established patient office or other outpatient visit, 40-54 minutes | 88 | 63 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 87 | 32 |
| New patient office or other outpatient visit, 60-74 minutes | 65 | 65 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 39 | 39 |
| Hemodialysis procedure with physician evaluation | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Farxiga (dapagliflozin propanediol) Other prescribers in Stanford, CA | 201 |
| Chlorthalidone Other prescribers in Stanford, CA | 76 |
| Losartan Potassium Other prescribers in Stanford, CA | 71 |
| Amlodipine Besylate Other prescribers in Stanford, CA | 58 |
| Jardiance (empagliflozin) Other prescribers in Stanford, CA | 55 |
| Furosemide Other prescribers in Stanford, CA | 45 |
| Lisinopril Other prescribers in Stanford, CA | 40 |
| Carvedilol Other prescribers in Stanford, CA | 35 |
| Lokelma (sodium zirconium cyclosilicate) Other prescribers in Stanford, CA | 23 |
| Atorvastatin Calcium Other prescribers in Stanford, CA | 22 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $87,244 in research payments for these studies, mostly to the institutions running them.
- A phase 3,randomised,double blind,active controlled study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease ckd …
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.